NASDAQ:ABMD
Delisted

Abiomed Stock News

etoro logo Buy ABMD
*Your capital is at risk
$381.02
+0 (+0%)
At Close: Mar 20, 2023
Most S&P 500 investors got a little gain this month. But investors willing to look off the beaten path found huge gains.

Here's Why You Should Hold on to Abiomed (ABMD) Stock Now

03:05pm, Tuesday, 22'nd Nov 2022 Zacks Investment Research
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.

Bear Market Blues? 3 of the Best Stocks to Own in 2023

11:30am, Saturday, 19'th Nov 2022 The Motley Fool
2023 could be a big year for each of these healthcare companies.
Buffett loves stocks that pay dividends. Is it any wonder Berkshire Hathaway is poised to collect more than $6 billion worth of them next year?

Better Buy: Johnson & Johnson vs. Abbott Laboratories

02:37pm, Thursday, 10'th Nov 2022 The Motley Fool
These two healthcare giants are among the safest stocks investors can buy right now.
The company is planting seeds for future growth.
The company is planting seeds for future growth.

2 Healthcare Stocks You Can Buy and Hold for the Next Decade

03:07pm, Tuesday, 08'th Nov 2022 The Motley Fool
These robust businesses will be around well beyond the next 10 years.

3 No-Brainer Stocks to Buy in a Downturn

02:45pm, Tuesday, 08'th Nov 2022 The Motley Fool
These companies thrive when others falter.

Johnson & Johnson's Big Purchase, Amazon's New Moves, and More

02:45pm, Saturday, 05'th Nov 2022 The Motley Fool
Plus, we run through some shortcuts that could help you with your financial planning.

Wall Street Breakfast: What Moved Markets

12:21pm, Saturday, 05'th Nov 2022 Seeking Alpha
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.

Is Johnson & Johnson's Purchase of Abiomed Good for Investors?

11:25am, Saturday, 05'th Nov 2022 The Motley Fool
The $16.6 billion acquisition shakes up MedTech.

Beat the Dow Jones With This Unstoppable Dividend Stock

10:00am, Saturday, 05'th Nov 2022 The Motley Fool
Johnson & Johnson has outperformed the Dow so far this year.
The $16.6 billion acquisition shakes up MedTech.
Johnson & Johnson has outperformed the Dow so far this year.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE